Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders

S. Yamagishi, K. Nakamura, T. Matsui, H. Inoue, M. Takeuchi

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences